(Val⁴)-Angiotensin III is a variant peptide applied to evaluate residue-specific influences on receptor affinity and peptide conformation. Its substitution at position four enables targeted mapping of structure-activity relationships. Researchers analyze its conformational behavior to assess binding dynamics. The molecule supports comparative exploration of angiotensin fragment function.
CAT No: A15096
CAS No:16376-83-3
Synonyms/Alias:(VAL4)-ANGIOTENSIN III;(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid;100900-28-5;FV108532;PD133157;H-Arg-Val-Tyr-Val-His-Pro-Phe-OH; H-RVYVHPF-OH;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More